Register entry

Parke-Davis Div of Pfizer Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
9
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

9

9 active NDC listings: 9 human prescription drug. By marketing category: NDA 7, ANDA 2.

Dosage formNDCs
capsule4
solution2
tablet, film coated2
tablet, chewable1
RouteNDCs
oral9
Labeller name on the listingNDCs
parke-davis div of pfizer inc9
Catalogue

Marketed products

9
BrandGeneric nameForm / routeNDC
Celontinmethsuximidecapsule, oral0071-0525NDA
Dilantin InfatabsPhenytointablet, chewable, oral0071-0007ANDA
Lopidgemfibroziltablet, film coated, oral0071-0737NDA
LyricaPREGABALINcapsule, oral0071-1018NDA
NardilPhenelzine Sulfatetablet, film coated, oral0071-0350NDA
Neurontingabapentincapsule, oral0071-0805NDA
Neurontingabapentinsolution, oral0071-2012NDA
ZarontinEthosuximidecapsule, oral0071-0237NDA
ZarontinEthosuximidesolution, oral0071-2418ANDA
Compare

Other companies listing ethosuximide

Enquiry

Common questions

Is Parke-Davis Div of Pfizer Inc FDA approved?
Parke-Davis Div of Pfizer Inc holds no registered establishment of its own; 9 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Parke-Davis Div of Pfizer Inc make?
9 products are listed under Parke-Davis Div of Pfizer Inc in the openFDA NDC Directory, most often as capsule; solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.